Point

Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy

Pedro Isaacsson Velho, Mario Eisenberger

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)223-226
Number of pages4
JournalOncology (Williston Park, N.Y.)
Volume32
Issue number5
StatePublished - May 15 2018

Fingerprint

Prostatic Neoplasms
Drug Therapy
abiraterone

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Point : Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy. / Isaacsson Velho, Pedro; Eisenberger, Mario.

In: Oncology (Williston Park, N.Y.), Vol. 32, No. 5, 15.05.2018, p. 223-226.

Research output: Contribution to journalArticle

@article{cf2cbe411c234c828344bf4b0b3663e0,
title = "Point: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy",
author = "{Isaacsson Velho}, Pedro and Mario Eisenberger",
year = "2018",
month = "5",
day = "15",
language = "English (US)",
volume = "32",
pages = "223--226",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "5",

}

TY - JOUR

T1 - Point

T2 - Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy

AU - Isaacsson Velho, Pedro

AU - Eisenberger, Mario

PY - 2018/5/15

Y1 - 2018/5/15

UR - http://www.scopus.com/inward/record.url?scp=85050686587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050686587&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 223

EP - 226

JO - Oncology

JF - Oncology

SN - 0890-9091

IS - 5

ER -